Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia-Reference-Cited by-同舟云学术

Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia

Published:2016-03 Issue: Volume:170 Page:234-239
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Bjoraker Kendra J.^ORCID,Swanson Michael A.,Coughlin Curtis R.,Christodoulou John,Tan Ee S.,Fergeson Mark,Dyack Sarah,Ahmad Ayesha,Friederich Marisa W.,Spector Elaine B.,Creadon-Swindell Geralyn^ORCID,Hodge M. Antoinette,Gaughan Sommer,Burns Casey,Van Hove Johan L.K.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference33 articles.

1. Comprehensive mutation analysis of GLDC, AMT and GCSH in nonketotic hyperglycinemia;Kure;Hum Mutat,2006

2. Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy;Conter;J Inherit Metab Dis,2006

3. Prediction of long-term outcome in glycine encephalopathy: a clinical survey;Hennermann;J Inherit Metab Dis,2012

4. Atypical variants of nonketotic hyperglycinemia;Dinopoulos;Mol Genet Metab,2005

5. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia;Swanson;Ann Neurol,2015

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Acute Motor Exacerbations (SAME) across Metabolic, Developmental and Genetic Disorders;Movement Disorders;2024-08-09

2. AAV-mediated expression of mouse or human GLDC normalises metabolic biomarkers in a GLDC-deficient mouse model of Non-Ketotic Hyperglycinemia;Molecular Genetics and Metabolism;2024-07

3. Deep postnatal phenotyping of a new mouse model of nonketotic hyperglycinemia;Journal of Inherited Metabolic Disease;2024-06-05

4. The behavioral phenotype of children and adolescents with attenuated non-ketotic hyperglycinemia, intermediate to good subtype;Orphanet Journal of Rare Diseases;2024-04-08

5. Homozygosity for disease‐causing variants in AMT and GLDC in a patient with severe nonketotic hyperglycinemia;American Journal of Medical Genetics Part A;2024-04-04